tiprankstipranks
Trending News
More News >
Aurinia Pharmaceuticals (AUPH)
:AUPH
US Market
Advertisement

Aurinia Pharmaceuticals (AUPH) Ratios

Compare
2,074 Followers

Aurinia Pharmaceuticals Ratios

AUPH's free cash flow for Q2 2025 was $0.90. For the 2025 fiscal year, AUPH's free cash flow was decreased by $ and operating cash flow was $0.33. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.23 5.50 9.60 12.63 13.11
Quick Ratio
4.63 4.99 9.06 12.15 12.67
Cash Ratio
0.68 0.63 2.04 5.71 8.51
Solvency Ratio
0.48 -0.39 -1.61 -2.77 -1.81
Operating Cash Flow Ratio
1.18 -0.43 -1.72 -3.88 -2.18
Short-Term Operating Cash Flow Coverage
0.00 -1.24 -84.97 -148.91 -88.65
Net Current Asset Value
$ 241.71M$ 254.69M$ 377.11M$ 449.05M$ 363.52M
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.18 0.02 0.02 0.02
Debt-to-Equity Ratio
0.24 0.26 0.02 0.02 0.02
Debt-to-Capital Ratio
0.20 0.21 0.02 0.02 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.50 1.45 1.16 1.13 1.14
Debt Service Coverage Ratio
18.65 -2.14 -17.42 -168.28 -130.49
Interest Coverage Ratio
11.46 -33.04 -21.78 0.00 0.00
Debt to Market Cap
0.00 0.02 <0.01 <0.01 <0.01
Interest Debt Per Share
0.62 0.70 0.09 0.07 0.07
Net Debt to EBITDA
0.33 -0.77 0.83 1.26 2.56
Profitability Margins
Gross Profit Margin
89.51%91.94%95.77%97.61%-0.42%
EBIT Margin
25.77%-42.56%-79.35%-395.15%-208.09%
EBITDA Margin
33.25%-35.92%-77.33%-389.09%-205.35%
Operating Profit Margin
19.99%-52.24%-83.17%-396.31%-208.09%
Pretax Profit Margin
24.02%-44.14%-79.35%-395.15%-205.06%
Net Profit Margin
23.31%-44.45%-80.71%-396.81%-204.88%
Continuous Operations Profit Margin
23.31%-44.45%-80.71%-396.81%-204.88%
Net Income Per EBT
97.04%100.71%101.72%100.42%99.91%
EBT Per EBIT
120.14%84.49%95.41%99.71%98.55%
Return on Assets (ROA)
12.07%-14.24%-22.97%-33.30%-22.15%
Return on Equity (ROE)
16.72%-20.64%-26.68%-37.77%-25.18%
Return on Capital Employed (ROCE)
12.26%-19.47%-26.24%-35.95%-24.16%
Return on Invested Capital (ROIC)
11.43%-17.99%-26.58%-35.95%-24.05%
Return on Tangible Assets
12.16%-14.37%-23.29%-33.83%-22.60%
Earnings Yield
3.63%-6.06%-17.65%-6.12%-6.27%
Efficiency Ratios
Receivables Turnover
6.49 7.29 9.94 2.96 0.00
Payables Turnover
8.24 3.27 1.83 0.28 19.10
Inventory Turnover
0.59 0.36 0.23 0.06 3.61
Fixed Asset Turnover
2.91 1.51 15.66 4.65 4.88
Asset Turnover
0.52 0.32 0.28 0.08 0.11
Working Capital Turnover Ratio
0.78 0.47 0.31 0.11 0.15
Cash Conversion Cycle
634.23 962.80 1.43K 5.29K 81.90
Days of Sales Outstanding
56.26 50.10 36.72 123.37 0.00
Days of Inventory Outstanding
622.29 1.02K 1.60K 6.47K 101.01
Days of Payables Outstanding
44.32 111.63 198.93 1.30K 19.11
Operating Cycle
678.55 1.07K 1.63K 6.59K 101.01
Cash Flow Ratios
Operating Cash Flow Per Share
0.67 -0.23 -0.56 -1.22 -0.59
Free Cash Flow Per Share
0.67 -0.24 -0.56 -1.23 -0.65
CapEx Per Share
<0.01 <0.01 <0.01 0.01 0.06
Free Cash Flow to Operating Cash Flow
1.00 1.02 1.00 1.01 1.11
Dividend Paid and CapEx Coverage Ratio
313.95 -46.60 -272.36 -105.06 -9.51
Capital Expenditure Coverage Ratio
313.95 -46.60 -272.36 -105.06 -9.51
Operating Cash Flow Coverage Ratio
1.13 -0.34 -9.83 -18.04 -8.31
Operating Cash Flow to Sales Ratio
0.36 -0.19 -0.59 -3.46 -1.39
Free Cash Flow Yield
5.84%-2.65%-13.02%-5.38%-4.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
27.51 -16.50 -5.67 -16.35 -15.96
Price-to-Sales (P/S) Ratio
6.08 7.34 4.57 64.88 32.69
Price-to-Book (P/B) Ratio
4.98 3.41 1.51 6.18 4.02
Price-to-Free Cash Flow (P/FCF) Ratio
17.11 -37.67 -7.68 -18.59 -21.22
Price-to-Operating Cash Flow Ratio
18.00 -38.48 -7.71 -18.76 -23.45
Price-to-Earnings Growth (PEG) Ratio
0.57 0.57 0.12 -0.27 0.46
Price-to-Fair Value
4.98 3.41 1.51 6.18 4.02
Enterprise Value Multiple
18.61 -21.20 -5.08 -15.42 -13.36
Enterprise Value
1.61B 1.34B 526.99M 2.74B 1.37B
EV to EBITDA
18.61 -21.20 -5.08 -15.42 -13.36
EV to Sales
6.19 7.61 3.93 59.98 27.43
EV to Free Cash Flow
17.42 -39.10 -6.60 -17.18 -17.80
EV to Operating Cash Flow
17.37 -39.94 -6.63 -17.35 -19.68
Tangible Book Value Per Share
2.38 2.60 2.81 3.64 3.36
Shareholders’ Equity Per Share
2.41 2.64 2.86 3.70 3.44
Tax and Other Ratios
Effective Tax Rate
0.03 >-0.01 -0.02 >-0.01 <0.01
Revenue Per Share
1.87 1.23 0.94 0.35 0.42
Net Income Per Share
0.44 -0.54 -0.76 -1.40 -0.87
Tax Burden
0.97 1.01 1.02 1.00 1.00
Interest Burden
0.93 1.04 1.00 1.00 0.99
Research & Development to Revenue
0.09 0.28 0.34 1.12 1.00
SG&A to Revenue
0.37 1.11 1.47 3.76 1.92
Stock-Based Compensation to Revenue
0.07 0.26 0.24 0.69 0.35
Income Quality
1.53 0.43 0.74 0.87 0.68
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis